Literature DB >> 15820424

Possible association between the gamma-aminobutyric acid type B receptor 1 (GABBR1) gene and schizophrenia.

Gwyneth Zai1, Nicole King, Gregory W H Wong, Cathy L Barr, James L Kennedy.   

Abstract

Schizophrenia (SCZ) is a severe neuropsychiatric disorder with a genetic component. The major inhibitory GABA-(gamma-aminobutyric acid) ergic system may be involved. The GABA type B receptor 1 (GABBR1) gene has been localized to 6p21.3, a region linked to SCZ. We therefore investigated five polymorphisms (A-7265G, C10497G, Ser-491-Ser-T1473C, Phe-659-Phe-T1977C, and 3'-UTR A33795G substitutions) in the GABBR1 gene in a sample of 101 DSM-IV SCZ probands and their families, 150 unrelated affected individuals matched with 150 healthy controls, using the transmission disequilibrium test (TDT) and case-control analysis. We did not observe biased transmission of alleles in any of the polymorphisms individually and haplotypes within the gene to SCZ probands. However, a weak significant difference was observed in the A-7265G polymorphism between the allelic frequency (chi2 = 4.310, P = 0.038) and a trend was observed between the genotype frequency (chi2 = 4.970, 2 df, P = 0.083) of SCZ individuals and controls. Further investigations of the role of GABBR1 in SCZ are warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820424     DOI: 10.1016/j.euroneuro.2004.12.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  11 in total

1.  In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.

Authors:  Carolyn I Rodriguez; Lawrence S Kegeles; Amanda Levinson; R Todd Ogden; Xiangling Mao; Matthew S Milak; Donna Vermes; Shan Xie; Liane Hunter; Pamela Flood; Holly Moore; Dikoma C Shungu; Helen B Simpson
Journal:  Psychiatry Res       Date:  2015-06-06       Impact factor: 3.222

2.  Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study.

Authors:  S Hossein Fatemi; Timothy D Folsom; Paul D Thuras
Journal:  Schizophr Res       Date:  2011-02-08       Impact factor: 4.939

Review 3.  GABA(B) receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implications.

Authors:  Joshua Kantrowitz; Leslie Citrome; Daniel Javitt
Journal:  CNS Drugs       Date:  2009-08       Impact factor: 5.749

4.  A preliminary genetic association study of GAD1 and GABAB receptor genes in patients with treatment-resistant schizophrenia.

Authors:  Atsuhiro Miyazawa; Nobuhisa Kanahara; Masanobu Kogure; Ikuo Otsuka; Satoshi Okazaki; Yoshinori Watanabe; Fumiaki Yamasaki; Yusuke Nakata; Yasunori Oda; Akitoyo Hishimoto; Masaomi Iyo
Journal:  Mol Biol Rep       Date:  2021-11-29       Impact factor: 2.316

5.  Variants in GABBR1 Gene Are Associated with Methamphetamine Dependence and Two Years' Relapse after Drug Rehabilitation.

Authors:  Yan Zhao; Sufang Peng; Haifeng Jiang; Jiang Du; Shunying Yu; Min Zhao
Journal:  J Neuroimmune Pharmacol       Date:  2018-08-24       Impact factor: 4.147

6.  mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism.

Authors:  S Hossein Fatemi; Teri J Reutiman; Timothy D Folsom; Robert J Rooney; Diven H Patel; Paul D Thuras
Journal:  J Autism Dev Disord       Date:  2010-06

7.  Expression of GABA(B) receptors is altered in brains of subjects with autism.

Authors:  S Hossein Fatemi; Timothy D Folsom; Teri J Reutiman; Paul D Thuras
Journal:  Cerebellum       Date:  2009-03       Impact factor: 3.847

Review 8.  The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines.

Authors:  Tomasz Boczek; Joanna Mackiewicz; Marta Sobolczyk; Julia Wawrzyniak; Malwina Lisek; Bozena Ferenc; Feng Guo; Ludmila Zylinska
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

9.  Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms.

Authors:  H Le-Niculescu; Y Balaraman; S D Patel; M Ayalew; J Gupta; R Kuczenski; A Shekhar; N Schork; M A Geyer; A B Niculescu
Journal:  Transl Psychiatry       Date:  2011-05-24       Impact factor: 6.222

Review 10.  Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.

Authors:  James Varley; Angela Vincent; Sarosh R Irani
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.